Diffusion of ertapenem into bone and synovial tissues

被引:24
作者
Boselli, E. [1 ]
Breilh, D.
Djabarouti, S.
Bel, J. C.
Saux, M. C.
Allaouchiche, B.
机构
[1] Dept Anaesthesiol & Intens Care, Lyon, France
[2] Haut Leveque Hosp, Clin Pharmacokinet Lab, Pessac, France
关键词
diffusion; pharmacokinetics; bone infection;
D O I
10.1093/jac/dkm296
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The degree of penetration of an antibiotic into the infected site is an important criterion for therapeutic success. Ertapenem is a new carbapenem, exhibiting activity against most Gram-positive and Gram-negative aerobic and anaerobic bacteria commonly recovered from community-acquired infections. However, no studies concerning its diffusion into bone and synovial tissue are available. Our objective was to quantify ertapenem bone and synovial tissue penetration and to compare our data with the MIC(90)s for causative pathogens. Patients and methods: In an open-label study, 18 patients who were undergoing elective total hip replacement received a single, parenteral, 1 g dose of ertapenem. One serum, one cortical and cancellous bone and one synovial tissue sample was collected per patient a median [interquartile range (IQR)] of 1.6 (1.5-1.7), 12.4 (11.9-13.1) or 23.8 h (22.6-25.2) later and analysed by HPLC. Results: The median ( IQR) serum concentrations of ertapenem were 70.1 (56.1-75.9), 10.0 (9.1-11.2) and 2.6 mg/ L ( 2.3-3.0), respectively, at the different time points. The median ( IQR) cancellous bone tissue concentrations were 13.2 (10.2-14.8), 1.9 (1.7-2.1) and 0.6 mg/ g (0.4-0.6) at the different time points, corresponding to a median (IQR) tissue/serum penetration ratio of 0.19 (0.18-0.23). The median (IQR) cortical bone tissue concentrations were 8.0 (6.5-9.5), 1.3 (1.2-1.3) and 0.3 mg/ g (0.3-0.4) at the different time points, corresponding to a median (IQR) tissue/serum penetration ratio of 0.13 (0.12-0.14). The median (IQR) synovial tissue concentrations were 26.2 mg/ g (22.7-28.4), 4.0 mg/L (3.7-4.4) and 1.0 mg/L (0.9-1.2) at the different time points, corresponding to a median (IQR) tissue/serum penetration ratio of 0.41 (0.39-0.42). Conclusions: The concentrations after an ertapenem 1 g dose achieved in cancellous and cortical bone tissue and in synovial tissue were greater than the MIC90s for most aerobic organisms for 24h, and for 12 to 24 h for anaerobic bacteria in healthy volunteers undergoing total hip replacement.
引用
收藏
页码:893 / 896
页数:4
相关论文
共 10 条
[1]  
Boselli E, 1999, PRESSE MED, V28, P2265
[2]   Determination of free ertapenem in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection [J].
Gordien, JB ;
Boselli, E ;
Fleureau, C ;
Allaouchiche, B ;
Janvier, G ;
Lalaude, O ;
Saux, MC ;
Breilh, D .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 830 (02) :218-223
[3]   Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties [J].
Hammond, ML .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 :7-9
[4]   Ertapenem - A review of its use in the treatment of bacterial infections [J].
Keating, GM ;
Perry, CM .
DRUGS, 2005, 65 (15) :2151-2178
[5]   Osteomyelitis [J].
Lew, DP ;
Waldvogel, FA .
LANCET, 2004, 364 (9431) :369-379
[6]   Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial [J].
Lipsky, BA ;
Armstrong, DG ;
Citron, DM ;
Tice, AD ;
Morgenstern, DE ;
Abramson, MA .
LANCET, 2005, 366 (9498) :1695-1703
[7]   Properties and potential of ertapenem [J].
Livermore, DM ;
Sefton, AM ;
Scott, GM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) :331-344
[8]   Ertapenem, the first of a new group of carbapenems [J].
Shah, PM ;
Isaacs, RD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :538-542
[9]   In vitro activity of ertapenem:: review of recent studies [J].
Wexler, HM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 :11-21
[10]   Large stress reduction induced by sp2 clustering in tetrahedral amorphous carbon films [J].
Zhang, YB ;
Lau, SP ;
Prawer, S ;
Tay, BK .
SCIENCE AND TECHNOLOGY OF NANOMATERIALS - ICMAT 2003, 2005, 23 :39-42